West Pharmaceutical Services, Inc. (WST) short interest & options flow
NYSEWest Pharmaceutical Services delivered its Q3 results on October 29 and the immediate reaction was clear: every analyst who covered the name raised their price target the following morning, and the stock closed the week at $412.62, up 5.2% from Monday's open. The analyst response was unanimous in direction if not in magnitude. Citigroup lifted its target from $412 to $494, TD Cowen…
WST cost to borrow doubles to 0.39% in one week, rising from 0.18% as borrow scarcity tightens despite low short interest at 3.1% of float.
- Market cap
- $27.85B
- Next earnings
- 11 Feb 2027
Key data as of 10 Nov 2026
WST news and analysis
RSSNo long-form analysis yet for WST. Pulse alerts and the live data picture are available on ORTEX.
Open WST on ORTEX →Want the live picture for WST?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for WST — free to start on ORTEX.
Sign up for free →Open WST on ORTEX